Paper526002
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
Wallace RJ and 2 others. Antimicrob Agents Chemother, 1979. Cited by 109 papers, by iCite.
Cite this record
ConductScience Library. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Papers, record 526002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Mycobacterium | Major topic |
| Aminoglycosides | |
| Culture Media | |
| Erythromycin | |
| Microbial Sensitivity Tests | |
| Tetracyclines |
Source PubMed
References6
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 475359 | Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/475359 | PubMed |
| 2 | 726085 | Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum. | Tubercle | 1978 | https://conductscience.org/library/papers/726085 | PubMed |
| 3 | 5544146 | In-vitro activity of erythromycin against atypical mycobacteria. | J Infect Dis | 1971 | https://conductscience.org/library/papers/5544146 | PubMed |
| 4 | 900925 | Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents. | Antimicrob Agents Chemother | 1977 | https://conductscience.org/library/papers/900925 | PubMed |
| 5 | 4746583 | Clinical significance of Mycobacterium fortuitum infections in pulmonary disease. | Am Rev Respir Dis | 1973 | https://conductscience.org/library/papers/4746583 | PubMed |
| 6 | 632627 | In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. | J Infect Dis | 1978 | https://conductscience.org/library/papers/632627 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42498785 | Luteoagmacins A and B, new antimicrobial agmatine derivatives from a hot spring water-derived Luteococcus sp. | J Antibiot (Tokyo) | 2026 | https://conductscience.org/library/papers/42498785 | PubMed |
| 41635493 | Cephalexin-loaded polyvinyl alcohol/graphene oxide thin films as antibacterial wound dressing. | RSC Adv | 2026 | https://conductscience.org/library/papers/41635493 | PubMed |
| 39356365 | Design, synthesis, and computational analysis (molecular docking, DFT, MEP, RDG, ELF) of diazepine and oxazepine sulfonamides: biological evaluation for in vitro and in vivo anti-inflammatory, antimicrobial, and cytotoxicity predictions. | Mol Divers | 2025 | https://conductscience.org/library/papers/39356365 | PubMed |
| 38024963 | A synergistic investigation of azo-thiazole derivatives incorporating thiazole moieties: a comprehensive exploration of their synthesis, characterization, computational insights, solvatochromism, and multimodal biological activity assessment. | RSC Adv | 2023 | https://conductscience.org/library/papers/38024963 | PubMed |
| 37606184 | Review of methods for detection and characterization of non-tuberculous mycobacteria in aquatic organisms. | J Vet Diagn Invest | 2024 | https://conductscience.org/library/papers/37606184 | PubMed |
| 34946162 | Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria. | Microorganisms | 2021 | https://conductscience.org/library/papers/34946162 | PubMed |
| 33573039 | Drug Resistance in Nontuberculous Mycobacteria: Mechanisms and Models. | Biology (Basel) | 2021 | https://conductscience.org/library/papers/33573039 | PubMed |
| 27782812 | Real time PCR for the rapid identification and drug susceptibility of Mycobacteria present in Bronchial washings. | BMC Infect Dis | 2016 | https://conductscience.org/library/papers/27782812 | PubMed |
| 23968779 | Mycobacterium chelonae abscesses associated with biomesotherapy, Australia, 2008. | Emerg Infect Dis | 2013 | https://conductscience.org/library/papers/23968779 | PubMed |
| 22763637 | Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. | Clin Microbiol Rev | 2012 | https://conductscience.org/library/papers/22763637 | PubMed |
| 22673307 | Tetracycline resistance and presence of tetracycline resistance determinants tet(V) and tap in rapidly growing mycobacteria from agricultural soils and clinical isolates. | Microbes Environ | 2012 | https://conductscience.org/library/papers/22673307 | PubMed |
| 17088352 | Characterization of the Mycobacterium tuberculosis sigma factor SigM by assessment of virulence and identification of SigM-dependent genes. | Infect Immun | 2007 | https://conductscience.org/library/papers/17088352 | PubMed |
| 11716590 | Infection of the subcutis and skin of cats with rapidly growing mycobacteria: a review of microbiological and clinical findings. | J Feline Med Surg | 2000 | https://conductscience.org/library/papers/11716590 | PubMed |
| 10325306 | Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. | J Clin Microbiol | 1999 | https://conductscience.org/library/papers/10325306 | PubMed |
| 8793407 | Mycobacterium fortuitum bacteremia in an immunocompromised patient with a long-term venous catheter. | Eur J Clin Microbiol Infect Dis | 1996 | https://conductscience.org/library/papers/8793407 | PubMed |
| 8253968 | DNA large restriction fragment patterns of sporadic and epidemic nosocomial strains of Mycobacterium chelonae and Mycobacterium abscessus. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8253968 | PubMed |
| 7989530 | Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum. | J Clin Microbiol | 1994 | https://conductscience.org/library/papers/7989530 | PubMed |
| 7665643 | Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria. | J Clin Microbiol | 1995 | https://conductscience.org/library/papers/7665643 | PubMed |
| 7325629 | Susceptibility of Mycobacterium marinum to tetracyclines and aminoglycosides. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7325629 | PubMed |
| 7247358 | In vitro susceptibility of Mycobacterium fortuitum to cefoxitin. | Antimicrob Agents Chemother | 1981 | https://conductscience.org/library/papers/7247358 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/526002
GET https://conductscience.org/api/papers/v1/526002/cited_by?page=2